[ad_1]
Gytis Andrulionis, head of the State Drug Control Service (VVKT), informed BNS about this.
“Lithuania has 1.24 million doses of vaccine. In terms of citizens, 620 thousand people would be assigned because one person needs two doses,” he said.
The European Commission approved on Wednesday a contract with the pharmaceutical companies BioNTech and Pfizer for 200 million. dose of coronavirus vaccine. Another 100 million were also agreed. dose reservation.
According to G. Andrulionis, from the additionally reserved amount, Lithuania could receive 620 thousand. dose of vaccine.
“But they go according to a completely different schedule, later, with everyone’s approval. The base acquisition is exactly 200 million ”, he commented.
The head of the Drug Control Service also emphasized that although 1.24 million LTL was planned for Lithuania. dose of vaccine, the EC can be requested to increase this amount.
“If we express the desire to increase the amount of vaccine we plan to buy, it is an internal redistribution mechanism: each country can give in favor of others,” he said.
According to Andrulionis, the government must decide on the purchase of vaccines from BioNTech and Pfizer and the possible increase in their quantity, according to G. Andrulionis.
The government this week approved an offer from the Health Ministry to buy $ 1.5 million. doses of coronavirus vaccines from developing pharmaceutical companies Sanofi and GSK.
Lithuania has already made the decision to acquire 1.86 million from the pharmaceutical company AstraZeneca. doses of vaccines and 1.24 million from Janssen Pharmaceutica NV. dose, but this amount will be reduced to 700 thousand. dose. According to G. Andriulionis, this would be done according to the internal redistribution mechanism mentioned above.
Among other things, the Cabinet of Ministers has also decided that Lithuania and other European Union countries will participate in the procurement of all COVID-19 vaccines under development, which are being negotiated by the European Commission.
The aim is to ensure that Lithuania has a sufficient supply of effective vaccines. The government is determined to buy enough to vaccinate 70 percent of the country’s population.
Prime Minister Saulius Skvernelis has stated that the maximum amount Lithuania would have to pay for vaccines could be around 125 million. euros. However, he stressed that Lithuania could sell the surplus to the Eastern Partnership countries.
In addition to the four pre-agreements with AstraZeneca, Janssen Pharmaceutica NV, Sanofi-GSK and BioNTech, Pfizer, the European Commission has also successfully completed preparatory negotiations with CureVac and Moderna.
BioNTech and Pfizer announced Monday that they are developing 90 percent of the vaccine they are developing. effective protection against coronavirus. This, according to the companies, was demonstrated by the results of the ongoing phase III investigation.
The European Medicines Agency (EMA) announced earlier this week that it did not yet have clinical trial data from Pfizer to approve the vaccine, which manufacturers say is 90 percent effective.
It is not allowed to publish, quote or reproduce the information of the BNS news agency in the media and on websites without the written consent of the UAB “BNS”.
[ad_2]
